Author Index Volume 4 (2015)
The issue number is given in front of the pagination
Adams, W.H., see Beglinger, L.J. (3) 251-260
Alikhan, F.S., see Wegrzynowicz, M. (1) 17-36
Allen, N.D., see Mort, M. (2) 161-171
Armesto, D., see Cubo, E. (1) 75-85
Arning, L., C.N. Witt, J.T. Epplen and S. Stemmler, Genetic Counselling for Predictive Testing in Huntington’s Disease in One Centre since 1993. Gender-Specific Aspects of Decision-Making (1) 87-98
Aronin, N., see Johnson, E. (3) 219-229
Aronin, N., see Vodicka, P. (2) 187-201
Barker, R.A., see Mason, S. (1) 49-59
Barker, R.A., see Tedroff, J. (2) 131-140
Beglinger, L.J., W.H. Adams, J.G. Fiedorowicz, K. Duff, D. Langbehn, K. Biglan, J. Caviness, B. Olson and J.S. Paulsen, Practice Effects and Stability of Neuropsychological and UHDRS Tests Over Short Retest Intervals in Huntington Disease (3) 251-260
Bichell, T.J., see Wegrzynowicz, M. (1) 17-36
Biglan, K., see Beglinger, L.J. (3) 251-260
Bijlsma, E.K., see Oosterloo, M. (2) 141-148
Björkqvist, M., see McCourt, A.C. (4) 371-382
Bohlen, S., see Reilmann, R. (1) 37-47
Bowman, A.B., see Wegrzynowicz, M. (1) 17-36
Brooks, S.P., see Steventon, J.J. (2) 149-160
Camara, R.J., see Cubo, E. (1) 75-85
Carlisle, F.A., see Mort, M. (2) 161-171
Caviness, J., see Beglinger, L.J. (3) 251-260
Chase, K., see Johnson, E. (3) 219-229
Chua, P., see Poudel, G.R. (4) 325-332
Churchyard, A., see Poudel, G.R. (4) 325-332
Churchyard, A., see Vaportzis, E. (2) 119-130
Cole, J.H., see Gregory, S. (4) 333-346
Cornejo-Herrera, I.F., see Cornejo-Olivas, M.R. (1) 99-105
Cornejo-Olivas, M.R., M.A. Inca-Martinez, K. Espinoza-Huertas, D. Veliz-Otani, M.R. Velit-Salazar, V. Marca, O. Ortega, I.F. Cornejo-Herrera, S. Lindo-Samanamud, P. Mora-Alferez and P. Mazzetti, Clinical and Molecular Features of Late Onset Huntington Disease in a Peruvian Cohort (1) 99-105
Correia, K., D. Harold, K.-H. Kim, P. Holmans, L. Jones, M. Orth, R.H. Myers, S. Kwak, V.C. Wheeler, M.E. MacDonald, J.F. Gusella and J.-M. Lee, The Genetic Modifiers of Motor Onset Age (GeM MOA) Website: Genome-wide Association Analysis for Genetic Modifiers of Huntington’s Disease (3) 279-284
Coughlin, J.M., see Wegrzynowicz, M. (1) 17-36
Crane, K., see Tereshchenko, A. (3) 231-238
Craufurd, D., see Gregory, S. (3) 239-249
Craufurd, D., see McNally, G. (4) 347-369
Cubo, E., J. Rivadeneyra, D. Armesto, N. Mariscal, A. Martinez, R.J. Camara and on behalf of the Spanish members of the European Huntington Disease Network, Relationship between Nutritional Status and the Severity of Huntington’s Disease. A Spanish Multicenter Dietary Intake Study (1) 75-85
D’Cruz, G., see Smith, S. (3) 261-270
Dawson, J., see Tereshchenko, A. (3) 231-238
Deane, K.H.O., see Smith, S. (3) 261-270
Delatycki, M.B., see Mand, C.M. (3) 209-217
Deppe, M., see Reilmann, R. (1) 37-47
DiFiglia, M., see Johnson, E. (3) 219-229
DiFiglia, M., see Vodicka, P. (2) 187-201
Domínguez D, J.F., see Poudel, G.R. (4) 325-332
Dorsey, E.R., see Oster, E. (3) 271-277
Driscoll, S., see Poudel, G.R. (4) 325-332
Duff, K., see Beglinger, L.J. (3) 251-260
Duncan, R.E., see Mand, C.M. (3) 209-217
Durr, A., see Gregory, S. (3) 239-249
Durr, A., see Gregory, S. (4) 333-346
Eberly, S.W., see Oster, E. (3) 271-277
Egan, G.F., see Poudel, G.R. (4) 325-332
Elliston, L., see Mort, M. (2) 161-171
Epplen, J.T., see Arning, L. (1) 87-98
Espinoza-Huertas, K., see Cornejo-Olivas, M.R. (1) 99-105
Farmer, R.E., see Gregory, S. (4) 333-346
Fiedorowicz, J.G., see Beglinger, L.J. (3) 251-260
Flaherty, H., see Smith, S. (3) 261-270
Friedline, R.H., see Johnson, E. (3) 219-229
Frost, C., see Gregory, S. (4) 333-346
Garner, B., see Kreilaus, F. (4) 305-318
Georgiou-Karistianis, N., see Poudel, G.R. (4) 325-332
Georgiou-Karistianis, N., see Vaportzis, E. (2) 119-130
Gigengack, F., see Reilmann, R. (1) 37-47
Gillam, L., see Mand, C.M. (3) 209-217
Glajch, K.E. and G. Sadri-Vakili, Epigenetic Mechanisms Involved in Huntington’s Disease Pathogenesis (1) 1-15
Gonzalez-Alegre, P., see Tereshchenko, A. (3) 231-238
Gray, R., see Smith, S. (3) 261-270
Green, K.M., see Vodicka, P. (2) 187-201
Gregory, S., J.H. Cole, R.E. Farmer, E.M. Rees, R.A.C. Roos, R. Sprengelmeyer, A. Durr, B. Landwehrmeyer, H. Zhang, R.I. Scahill, S.J. Tabrizi, C. Frost and N.Z. Hobbs, Longitudinal Diffusion Tensor Imaging Shows Progressive Changes in White Matter in Huntington’s Disease (4) 333-346
Gregory, S., R.I. Scahill, K.K. Seunarine, C. Stopford, H. Zhang, J. Zhang, M. Orth, A. Durr, R.A.C. Roos, D.R. Langbehn, J.D. Long, H. Johnson, G. Rees, S.J. Tabrizi and D. Craufurd and the Track-HD investigators, Neuropsychiatry and White Matter Microstructure in Huntington’s Disease (3) 239-249
Guilarte, T.R., see Wegrzynowicz, M. (1) 17-36
Gusella, J.F., see Correia, K. (3) 279-284
Haider, S., see McCourt, A.C. (4) 371-382
Hannan, A.J., see Kreilaus, F. (4) 305-318
Hannan, A.J., see Renoir, T. (4) 297-303
Harold, D., see Correia, K. (3) 279-284
Harrison, D.J., see Steventon, J.J. (2) 149-160
Heidari, R., V. Monnier, E. Martin and H. Tricoire, Methylene Blue Partially Rescues Heart Defects in a Drosophila Model of Huntington’s Disease (2) 173-186
Hermann, S., see Reilmann, R. (1) 37-47
Hobbs, N.Z., see Gregory, S. (4) 333-346
Holmans, P., see Correia, K. (3) 279-284
Holt, H.K., see Wegrzynowicz, M. (1) 17-36
Hölzner, E., see Reilmann, R. (1) 37-47
Horton, M., see McNally, G. (4) 347-369
Hua, K., see Wegrzynowicz, M. (1) 17-36
Hughes, A.C., see Mort, M. (2) 161-171
Inca-Martinez, M.A., see Cornejo-Olivas, M.R. (1) 99-105
Iuliano, M., see Vodicka, P. (2) 187-201
Ivanecka, A., see Smith, S. (3) 261-270
Jacobs, A.H., see Reilmann, R. (1) 37-47
Jain, S., see Lenka, A. (4) 319-324
Jenner, A.M., see Kreilaus, F. (4) 305-318
Jetter, C.S., see Wegrzynowicz, M. (1) 17-36
Jhunjhunwala, K., see Lenka, A. (4) 319-324
Johnson, E., K. Chase, S. McGowan, E. Mondo, E. Pfister, E. Mick, R.H. Friedline, J.K. Kim, E. Sapp, M. DiFiglia and N. Aronin, Safety of Striatal Infusion of siRNA in a Transgenic Huntington’s Disease Mouse Model (3) 219-229
Johnson, H., see Gregory, S. (3) 239-249
Jones, D.K., see Steventon, J.J. (2) 149-160
Jones, L., see Correia, K. (3) 279-284
Jones, L., see Mort, M. (2) 161-171
Kamble, N.L., see Lenka, A. (4) 319-324
Kandasamy, M., see Lenka, A. (4) 319-324
Kayson-Rubin, E., see Oster, E. (3) 271-277
Kegel-Gleason, K.B., see Vodicka, P. (2) 187-201
Kim, J.K., see Johnson, E. (3) 219-229
Kim, K.-H., see Correia, K. (3) 279-284
Kreilaus, F., A.S. Spiro, A.J. Hannan, B. Garner and A.M. Jenner, Brain Cholesterol Synthesis and Metabolism is Progressively Disturbed in the R6/1 Mouse Model of Huntington’s Disease: A Targeted GC-MS/MS Sterol Analysis (4) 305-318
Kugel, H., see Reilmann, R. (1) 37-47
Kwak, S., see Correia, K. (3) 279-284
Landwehrmeyer, B., see Gregory, S. (4) 333-346
Langbehn, D., see Beglinger, L.J. (3) 251-260
Langbehn, D.R., see Gregory, S. (3) 239-249
Leavitt, B.R., see Mazarei, G. (2) 109-118
Lee, J.K., see Tereshchenko, A. (3) 231-238
Lee, J.-M., see Correia, K. (3) 279-284
Lenka, A., N.L. Kamble, V. Sowmya, K. Jhunjhunwala, R. Yadav, M. Netravathi, M. Kandasamy, N.S. Moily, M. Purushottam, S. Jain and P.K. Pal, Determinants of Onset of Huntington’s Disease with Behavioral Symptoms: Insight from 92 Patients (4) 319-324
Li, S., see Renoir, T. (4) 297-303
Lindo-Samanamud, S., see Cornejo-Olivas, M.R. (1) 99-105
Lippross, V., see Reilmann, R. (1) 37-47
Long, J.D., see Gregory, S. (3) 239-249
Loth, M.K., see Wegrzynowicz, M. (1) 17-36
Lücke, M., see Reilmann, R. (1) 37-47
MacDonald, M.E., see Correia, K. (3) 279-284
Mahdy, H.M., Huntington’s Disease in Arab Countries (3) 205-208
Mand, C.M., L. Gillam, R.E. Duncan and M.B. Delatycki, “I’m scared of being like mum”: The Experience of Adolescents Living in Families with Huntington Disease (3) 209-217
Marca, V., see Cornejo-Olivas, M.R. (1) 99-105
Mariscal, N., see Cubo, E. (1) 75-85
Martin, E., see Heidari, R. (2) 173-186
Martinez, A., see Cubo, E. (1) 75-85
Mason, S. and R.A. Barker, Rating Apathy in Huntington’s Disease: Patients and Companions Agree (1) 49-59
Mazarei, G. and B.R. Leavitt, Indoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington’s Disease (2) 109-118
Mazzetti, P., see Cornejo-Olivas, M.R. (1) 99-105
McCourt, A.C., J. Parker, E. Silajdžić, S. Haider, H. Sethi, S.J. Tabrizi, T.T. Warner and M. Björkqvist, Analysis of White Adipose Tissue Gene Expression Reveals CREB1 Pathway Altered in Huntington’s Disease (4) 371-382
McGlothan, J.L., see Wegrzynowicz, M. (1) 17-36
McGowan, S., see Johnson, E. (3) 219-229
McHugh, M., see Tereshchenko, A. (3) 231-238
McNally, G., H. Rickards, M. Horton and D. Craufurd, Exploring the Validity of the Short Version of the Problem Behaviours Assessment (PBA-s) for Huntington’s disease: A Rasch Analysis (4) 347-369
Mick, E., see Johnson, E. (3) 219-229
Mo, S., see Vodicka, P. (2) 187-201
Moily, N.S., see Lenka, A. (4) 319-324
Mondo, E., see Johnson, E. (3) 219-229
Monnier, V., see Heidari, R. (2) 173-186
Mora-Alferez, P., see Cornejo-Olivas, M.R. (1) 99-105
Mori, S., see Wegrzynowicz, M. (1) 17-36
Mort, M., F.A. Carlisle, A.J. Waite, L. Elliston, N.D. Allen, L. Jones and A.C. Hughes, Huntingtin Exists as Multiple Splice Forms in Human Brain (2) 161-171
Morton, A.J., see Wood, N.I. (1) 61-73
Myers, R.H., see Correia, K. (3) 279-284
Netravathi, M., see Lenka, A. (4) 319-324
Nguyen, H.P., see Reilmann, R. (1) 37-47
Nopoulos, P., see Tereshchenko, A. (3) 231-238
Oakes, D., see Oster, E. (3) 271-277
Olson, B., see Beglinger, L.J. (3) 251-260
Oosterloo, M., M.J. Van Belzen, E.K. Bijlsma and R.A.C. Roos, Is There Convincing Evidence that Intermediate Repeats in the HTT Gene Cause Huntington’s Disease? (2) 141-148
Ortega, O., see Cornejo-Olivas, M.R. (1) 99-105
Orth, M., see Correia, K. (3) 279-284
Orth, M., see Gregory, S. (3) 239-249
Osada, N., see Reilmann, R. (1) 37-47
Osmand, A.P., see Wegrzynowicz, M. (1) 17-36
Oster, E., S.W. Eberly, E.R. Dorsey, E. Kayson-Rubin, D. Oakes and I. Shoulson, Informativeness of Early Huntington Disease Signs about Gene Status (3) 271-277
Pal, P.K., see Lenka, A. (4) 319-324
Pang, T.Y., see Renoir, T. (4) 297-303
Parker, J., see McCourt, A.C. (4) 371-382
Paulsen, J.S., see Beglinger, L.J. (3) 251-260
Pfister, E., see Johnson, E. (3) 219-229
Piccini, P., see Roussakis, A.-A. (4) 287-296
Pomper, M.G., see Wegrzynowicz, M. (1) 17-36
Poudel, G.R., S. Driscoll, J.F. Domínguez D, J.C. Stout, A. Churchyard, P. Chua, G.F. Egan and N. Georgiou-Karistianis, Functional Brain Correlates of Neuropsychiatric Symptoms in Presymptomatic Huntington’s Disease: The IMAGE-HD Study (4) 325-332
Purushottam, M., see Lenka, A. (4) 319-324
Rees, E.M., see Gregory, S. (4) 333-346
Rees, G., see Gregory, S. (3) 239-249
Reilmann, R., V. Lippross, E. Hölzner, F. Gigengack, S. Bohlen, H. Kugel, M. Deppe, N. Osada, M. Lücke, O. Riess, H.P. Nguyen, S. von Hörsten, K. Schäfers, M. Schäfers, A.H. Jacobs and S. Hermann, FDG mPET Fails to Detect a Disease-Specific Phenotype in Rats Transgenic for Huntington’s Disease – A 15 Months Follow-up Study (1) 37-47
Renoir, T., T.Y. Pang, Y. Shikano, S. Li and A.J. Hannan, Loss of the Sexually Dimorphic Neuro-Inflammatory Response in a Transgenic Mouse Model of Huntington’s Disease (4) 297-303
Rickards, H., see McNally, G. (4) 347-369
Riess, O., see Reilmann, R. (1) 37-47
Rivadeneyra, J., see Cubo, E. (1) 75-85
Roos, R., see Tedroff, J. (2) 131-140
Roos, R.A.C., see Gregory, S. (3) 239-249
Roos, R.A.C., see Gregory, S. (4) 333-346
Roos, R.A.C., see Oosterloo, M. (2) 141-148
Rosser, A.E., see Steventon, J.J. (2) 149-160
Roussakis, A.-A. and P. Piccini, PET Imaging in Huntington’s Disease (4) 287-296
Sadri-Vakili, G., see Glajch, K.E. (1) 1-15
Sadri-Vakili, G., see Vodicka, P. (2) 187-201
Sapp, E., see Johnson, E. (3) 219-229
Sapp, E., see Vodicka, P. (2) 187-201
Scahill, R.I., see Gregory, S. (3) 239-249
Scahill, R.I., see Gregory, S. (4) 333-346
Schäfers, K., see Reilmann, R. (1) 37-47
Schäfers, M., see Reilmann, R. (1) 37-47
Sethi, H., see McCourt, A.C. (4) 371-382
Seunarine, K.K., see Gregory, S. (3) 239-249
Shaffer, S.A., see Vodicka, P. (2) 187-201
Shikano, Y., see Renoir, T. (4) 297-303
Shoulson, I., see Oster, E. (3) 271-277
Silajdžić, E., see McCourt, A.C. (4) 371-382
Smith, S., G. D’Cruz, R. Gray, H. Flaherty, A. Ivanecka and K.H.O. Deane, A Concept Map of What Helps People with HD Live with their Condition (3) 261-270
Soares, B.D., see Wegrzynowicz, M. (1) 17-36
Sowmya, V., see Lenka, A. (4) 319-324
Spiro, A.S., see Kreilaus, F. (4) 305-318
Sprengelmeyer, R., see Gregory, S. (4) 333-346
Squitieri, F., see Tedroff, J. (2) 131-140
Stemmler, S., see Arning, L. (1) 87-98
Steventon, J.J., D.J. Harrison, R.C. Trueman, A.E. Rosser, D.K. Jones and S.P. Brooks, In Vivo MRI Evidence that Neuropathology is Attenuated by Cognitive Enrichment in the Yac128 Huntington’s Disease Mouse Model (2) 149-160
Stopford, C., see Gregory, S. (3) 239-249
Stout, J.C., see Poudel, G.R. (4) 325-332
Stout, J.C., see Vaportzis, E. (2) 119-130
Tabrizi, S.J., see Gregory, S. (3) 239-249
Tabrizi, S.J., see Gregory, S. (4) 333-346
Tabrizi, S.J., see McCourt, A.C. (4) 371-382
Tedroff, J., S. Waters, R.A. Barker, R. Roos and F. Squitieri on behalf of the EHDN Registry Study Group, Antidopaminergic Medication is Associated with More Rapidly Progressive Huntington’s Disease (2) 131-140
Tereshchenko, A., M. McHugh, J.K. Lee, P. Gonzalez-Alegre, K. Crane, J. Dawson and P. Nopoulos, Abnormal Weight and Body Mass Index in Children with Juvenile Huntington’s Disease (3) 231-238
Tousley, A., see Vodicka, P. (2) 187-201
Tricoire, H., see Heidari, R. (2) 173-186
Trueman, R.C., see Steventon, J.J. (2) 149-160
Van Belzen, M.J., see Oosterloo, M. (2) 141-148
Vaportzis, E., N. Georgiou-Karistianis, A. Churchyard and J.C. Stout, Dual Task Performance May be a Better Measure of Cognitive Processing in Huntington’s Disease than Traditional Attention Tests (2) 119-130
Velit-Salazar, M.R., see Cornejo-Olivas, M.R. (1) 99-105
Veliz-Otani, D., see Cornejo-Olivas, M.R. (1) 99-105
Vodicka, P., S. Mo, A. Tousley, K.M. Green, E. Sapp, M. Iuliano, G. Sadri-Vakili, S.A. Shaffer, N. Aronin, M. DiFiglia and K.B. Kegel-Gleason, Mass Spectrometry Analysis of Wild-Type and Knock-in Q140/Q140 Huntington’s Disease Mouse Brains Reveals Changes in Glycerophospholipids Including Alterations in Phosphatidic Acid and Lyso-Phosphatidic Acid (2) 187-201
von Hörsten, S., see Reilmann, R. (1) 37-47
Waite, A.J., see Mort, M. (2) 161-171
Warner, T.T., see McCourt, A.C. (4) 371-382
Waters, S., see Tedroff, J. (2) 131-140
Wegrzynowicz, M., T.J. Bichell, B.D. Soares, M.K. Loth, J.L. McGlothan, F.S. Alikhan, K. Hua, J.M. Coughlin, H.K. Holt, C.S. Jetter, S. Mori, M.G. Pomper, A.P. Osmand, T.R. Guilarte and A.B. Bowman, Novel BAC Mouse Model of Huntington’s Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype (1) 17-36
Wheeler, V.C., see Correia, K. (3) 279-284
Witt, C.N., see Arning, L. (1) 87-98
Wood, N.I. and A.J. Morton, Social Behaviour is Impaired in the R6/2 Mouse Model of Huntington’s Disease (1) 61-73
Yadav, R., see Lenka, A. (4) 319-324
Zhang, H., see Gregory, S. (3) 239-249
Zhang, H., see Gregory, S. (4) 333-346
Zhang, J., see Gregory, S. (3) 239-249
